G-EYE™ colonoscopy
DeviceG-EYE™ colonoscopy
NCT Number: NCT01917513
The purpose of this study is to compare the adenoma detection rate of G-EYE™ high definition colonoscopy with that of standard high definition colonoscopy
Looking for future studies?
Notify Me50 year and older
All sexes
Interventional
Not applicable
Herlev Hospital, Harlev, Denmark
This is a multicenter, two-arm, randomized, open-label study intended to compare the detection rate obtained by performing G-EYE™ high definition colonoscopy vs. the detection rate obtained by performing high definition standard colonoscopy.
The study will enroll 1000 subjects. Consecutive adult subjects who were referred for elective colonoscopy will be asked to enroll into this randomized clinical study if the candidate meets the study inclusion and exclusion criteria.
Subjects will sign informed consent form and undergo randomization. The study includes a run-in preliminary phase of 270 patients to allow physicians to get familiar with the G-EYE™ endoscope.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
G-EYE™ colonoscopy
Standard Colonoscopy
Time frame: Approximalty following 14 days (histology results)
The percentage of patients with at least one adenoma or serrated lesion in the G-EYE™ group will be compared to the Standard group
Time frame: Up to 14 days (histology results)
The secondary outcome is a composite-each of the measured parameters will be reported as a single value for each arm
Smart Medical Systems Ltd.
Industry
Prospective Randomized Trial to Compare the Clinical Efficiency (Adenoma Detection Rate) of G-EYE™ HD Colonoscopy With Standard HD Colonoscopy
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05551052
Adenoma, Adenomas Colon
Chula Vista, California, United States
View Trial DetailsNCT04369053
Adenoma, Colon Cancer
Birmingham, Alabama, United States
View Trial DetailsNCT03688906
Adenoma, Adenoma Colon
Huntsville, Alabama, United States
View Trial DetailsNCT03072472
Adenoma, Colonic Diseases
South Shields, Tyne and Wear, United Kingdom
View Trial Details